10x Genomics (STU:1KJ) Ending Cash Position : €327.3 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is 10x Genomics Ending Cash Position?

10x Genomics's Ending Cash Position for the quarter that ended in Mar. 2024 was €327.3 Mil.

10x Genomics's quarterly Ending Cash Position increased from Sep. 2023 (€294.9 Mil) to Dec. 2023 (€329.5 Mil) but then declined from Dec. 2023 (€329.5 Mil) to Mar. 2024 (€327.3 Mil).

10x Genomics's annual Ending Cash Position declined from Dec. 2021 (€527.5 Mil) to Dec. 2022 (€214.6 Mil) but then increased from Dec. 2022 (€214.6 Mil) to Dec. 2023 (€329.5 Mil).

10x Genomics Ending Cash Position Historical Data

The historical data trend for 10x Genomics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10x Genomics Ending Cash Position Chart

10x Genomics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

428.84

566.07

527.53

214.62

329.46

10x Genomics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															317.37	305.38	294.91	329.46	327.32

10x Genomics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

10x Genomics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	208.483	+	120.98
	=	329.5

10x Genomics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	330.542	+	-3.223
	=	327.3

10x Genomics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of 10x Genomics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

10x Genomics (STU:1KJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (STU:1KJ) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

TXG:USA

Address

6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588

Website

https://www.10xgenomics.com

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

10x Genomics (STU:1KJ) Headlines

No Headlines